HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Efficacy of low doses of atypical neuroleptics (benzamides) in defect states].

Abstract
Recently many authors have hypothesized that the desinhibitory property of some neuroleptics at low doses might be related to the activation of the dopaminergic system and that, on the contrary, the overactivity of dopaminergic functions could underly the productive symptoms of some schizophrenic states. In order to test this bipolar hypothesis two independent controlled studies were set up using the same new benzamide compound (amisulpride) at different doses in the opposite forms of schizophrenia. According to the results of these studies there are evidences to sustain the assertion that amisulpride at low doses is efficient in negative symptoms of schizophrenia such as poverty of ideation, flattening of affect, inattention, asociality and that the same compound at high doses is also efficient in productive forms of schizophrenia. Whether this bipolar activity is due to the play of different kinds of receptors according to the dosage used, or is due to the dopaminergic blockade in different brain areas related to the dosage remains a problem to be solved.
AuthorsP Boyer
JournalAnnales medico-psychologiques (Ann Med Psychol (Paris)) Vol. 144 Issue 6 Pg. 593-9 (Jun 1986) ISSN: 0003-4487 [Print] France
Vernacular TitleEtude de l'efficacité de faibles doses de neuroleptiques atypiques (benzamides) dans les états déficitaires.
PMID2880542 (Publication Type: Journal Article)
Chemical References
  • Antipsychotic Agents
  • Sulpiride
  • Amisulpride
Topics
  • Amisulpride
  • Antipsychotic Agents (administration & dosage, therapeutic use)
  • Brief Psychiatric Rating Scale
  • Humans
  • Schizophrenia (diagnosis, drug therapy)
  • Sulpiride (administration & dosage, analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: